Trial · NCT07889817
Telerehabilitation After Lumbar Disc Herniation Surgery
NCT07889817, Not applicable, Completed, Hasan Kalyoncu University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Telerehabilitation After Lumbar Disc Herniation Surgery. Trials, record NCT07889817. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889817
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Telerehabilitation After Lumbar Disc Herniation Surgery
- NCT number
- NCT07889817
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 82 participants, actual
- Lead sponsor
- Hasan Kalyoncu University
- Conditions
- Lumbar Disc Herniation
- Interventions
- Home Exercise Program, Telerehabilitation-Based Exercise Program
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Functional Disability Assessed by the Oswestry Disability Index (ODI) | Baseline and 8 weeks | The Oswestry Disability Index (ODI) assesses functional disability associated with low back pain. Scores range from 0% to 100%, with higher scores indicating greater functional disability and a worse outcome. Changes in ODI scores were assessed from baseline to the end of the eight-week intervention period. |
| Primary | Pain Intensity Assessed by the Visual Analog Scale (VAS) | Baseline and 8 weeks | The Visual Analogue Scale (VAS) assesses pain intensity on a scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and a worse outcome. Changes in VAS scores were assessed from baseline to the end of the eight-week intervention period. |
| Primary | Physical Activity Assessed by the International Physical Activity Questionnaire-Short Form (IPAQ) | Baseline and 8 weeks | The International Physical Activity Questionnaire-Short Form (IPAQ-SF) assesses physical activity performed during the preceding seven days. Total physical activity is calculated using walking, moderate-intensity, and vigorous-intensity activities and expressed as metabolic equivalent task minutes per week (MET-min/week). Scores range from a minimum of 0 MET-min/week to no fixed maximum. Higher scores indicate greater levels of physical activity. Changes in total physical activity scores were assessed from baseline to the end of the eight-week intervention period. |
| Primary | Health-Related Quality of Life Assessed by the 36-Item Short Form Health Survey (SF-36) | Baseline and 8 weeks | The Short Form-36 (SF-36) Health Survey assesses health-related quality of life across eight domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better health-related quality of life. Changes in SF-36 scores were assessed from baseline to the end of the eight-week intervention period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889817
GET https://conductscience.org/api/trials/v1/NCT07889817/registered